CSL Behring has teamed up with HCmed to develop inhaled immunoglobulins. The collaborators are using HCmed’s AdheResp nebulizer platform to deliver plasma-derived immunoglobulins to the lungs of patients with respiratory conditions.
HCmed Innovations Co., Inc., a drug-device combination company focused on inhalation therapy, presented its latest brand, Pulmogine, in the 2019 ERS International Congress.
Handheld nebulizer manufacturer HCmed Innovations announced that it has accepted an invitation to build an R&D center and production facility in the newly opened Wuxi International Life Science Innovation Park, which is anchored by AstraZeneca.